INTELLIGUARD - European Union Trademark Information

The trademark application for INTELLIGUARD was filed on February 15, 2011, with 1 designated Nice Class under EUTM trademark no. 009738162. The trademark was successfully registered on July 18, 2011.

Trademark application with the EUIPO claimed priority of an earlier filing in United States on August 24, 2010 with a trademark application number 85/114,748.

Trademark holder MEPS Real-Time, Inc. was represented by MEWBURN ELLIS LLP (EUIPO registered representative, ID no. 10577).

No oppositions were raised during the publication period (90 days starting April 8, 2011).

Current trademark registration will expire on February 15, 2021.

TRADEMARK INFORMATION
Trademark Name INTELLIGUARD Trademark No. 009738162
Type Figurative Status Registered
Filling Date February 15, 2011 Registration Date July 18, 2011
NICE Classes 9 Basis EUTM
Reference ESH/FT6751291 Status Date July 20, 2011
Owner Information
Owner MEPS Real-Time, Inc.
Owner ID 495292
Legal Status Legal entity
Country US
Address MEPS Real-Time, Inc.
2875 Loker Avenue East
Carlsbad CA 92010
UNITED STATES
Representative Information
Representative MEWBURN ELLIS LLP
Representative ID 10577
Legal Status Legal person
Country GB
Address MEWBURN ELLIS LLP
City Tower
40 Basinghall Street
London
EC2V 5DE
UNITED KINGDOM
NICE CLASS Descriptions
Class Class Description
9
Computers, Software, Electronic instruments, & Scientific appliances

Automatic dispensing system comprising a cabinet, pharmacy reader, and patient bedside reader for storing and dispensing medication and medical supplies, and computer hardware and software for managing and tracking the inventory of medications and medical supplies stored and dispensed by the cabinet, pharmacy reader, and patient bedside reader, and controlling access to and operation of the cabinet.

Priority
Country Number Date Status
United States 85/114,748 August 24, 2010 Accepted

Disclaimer: The information provided on this page is considered public information by the European Union Intellectual Property Office and is provided for informational purposes only. It should not be construed as legal advice on any subject matter.